Cantel Medical EBIT

Cantel Medical (CMD) currently reports a EBIT of $130M as of April 2021. That compares with $59M in the prior-year period — up 121.5% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Cantel Medical's EBIT history and peer comparisons.

Cantel Medical's EBIT increased from $59M to $130M — a 121.5% year-over-year increase (period ending April 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cantel Medical's EBIT of $130M is lower than the Healthcare sector average of $23B. That is roughly 99.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Cantel Medical reported $130M in EBIT as of April 2021. That compares with $59M in the prior-year period — up 121.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $130M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Cantel Medical, and consider following CMD for alerts when major investors trade the stock.